Common Stock, Shares, Outstanding of ORAMED PHARMACEUTICALS INC. from 31 Aug 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
ORAMED PHARMACEUTICALS INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Aug 2011 to 30 Sep 2025.
  • ORAMED PHARMACEUTICALS INC. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 40,838,226, a 1.6% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

ORAMED PHARMACEUTICALS INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 40,838,226 +628,651 +1.6% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 40,845,087 +216,163 +0.53% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 40,850,455 +331,295 +0.82% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 39,919,545 -419,434 -1% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 40,209,575 -73,113 -0.18% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 40,628,924 +409,528 +1% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 40,519,160 +549,181 +1.4% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 40,338,979 +775,091 +2% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 40,282,688 +1,169,452 +3% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 40,219,396 +1,655,380 +4.3% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 39,969,979 +1,405,963 +3.6% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 39,563,888 +1,405,096 +3.7% 31 Dec 2022 10-K 06 Mar 2024 2023 FY
Q3 2022 39,113,236 +3,819,347 +11% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 38,564,016 +8,040,594 +26% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 38,564,016 +10,274,424 +36% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 38,158,792 +14,348,262 +60% 31 Dec 2021 10-K 06 Mar 2023 2022 FY
Q3 2021 35,293,889 +11,618,359 +49% 31 Aug 2021 10-QT 30 Mar 2022 2021 Q2
Q2 2021 30,523,422 +7,246,383 +31% 31 May 2021 10-Q 14 Jul 2021 2021 Q3
Q1 2021 28,289,592 +5,195,614 +22% 28 Feb 2021 10-Q 13 Apr 2021 2021 Q2
Q4 2020 23,810,530 +6,409,918 +37% 30 Nov 2020 10-Q 14 Jan 2021 2021 Q1
Q3 2020 23,675,530 +6,292,171 +36% 31 Aug 2020 10-K 24 Nov 2021 2021 FY
Q2 2020 23,277,039 +5,893,680 +34% 31 May 2020 10-Q 07 Jul 2020 2020 Q3
Q1 2020 23,093,978 +5,713,119 +33% 29 Feb 2020 10-Q 06 Apr 2020 2020 Q2
Q4 2019 17,400,612 +22,253 +0.13% 30 Nov 2019 10-Q 09 Jan 2020 2020 Q1
Q3 2019 17,383,359 +13,484 +0.08% 31 Aug 2019 10-K 24 Nov 2020 2020 FY
Q2 2019 17,383,359 +2,914,196 +20% 31 May 2019 10-Q 10 Jul 2019 2019 Q3
Q1 2019 17,380,859 +2,974,967 +21% 28 Feb 2019 10-Q 10 Apr 2019 2019 Q2
Q4 2018 17,378,359 +3,070,469 +21% 30 Nov 2018 10-Q 14 Jan 2019 2019 Q1
Q3 2018 17,369,875 +3,701,345 +27% 31 Aug 2018 10-K 27 Nov 2019 2019 FY
Q2 2018 14,469,163 +1,149,991 +8.6% 31 May 2018 10-Q 12 Jul 2018 2018 Q3
Q1 2018 14,405,892 +1,114,280 +8.4% 28 Feb 2018 10-Q 09 Apr 2018 2018 Q2
Q4 2017 14,307,890 +1,039,664 +7.8% 30 Nov 2017 10-Q 11 Jan 2018 2018 Q1
Q3 2017 13,668,530 +485,105 +3.7% 31 Aug 2017 10-K 28 Nov 2018 2018 FY
Q2 2017 13,319,172 +188,258 +1.4% 31 May 2017 10-Q 06 Jul 2017 2017 Q3
Q1 2017 13,291,612 +181,823 +1.4% 28 Feb 2017 10-Q 05 Apr 2017 2017 Q2
Q4 2016 13,268,226 +1,665,574 +14% 30 Nov 2016 10-Q 11 Jan 2017 2017 Q1
Q3 2016 13,183,425 +1,620,348 +14% 31 Aug 2016 10-K 29 Nov 2017 2017 FY
Q2 2016 13,130,914 +2,294,354 +21% 31 May 2016 10-Q 06 Jul 2016 2016 Q3
Q1 2016 13,109,789 +2,289,596 +21% 29 Feb 2016 10-Q 06 Apr 2016 2016 Q2
Q4 2015 11,602,652 +790,181 +7.3% 30 Nov 2015 10-Q 13 Jan 2016 2016 Q1
Q3 2015 11,563,077 +1,460,522 +14% 31 Aug 2015 10-K 25 Nov 2016 2016 FY
Q2 2015 10,836,560 +880,569 +8.8% 31 May 2015 10-Q 01 Jul 2015 2015 Q3
Q1 2015 10,820,193 +1,044,026 +11% 28 Feb 2015 10-Q 03 Apr 2015 2015 Q2
Q4 2014 10,812,471 +2,864,599 +36% 30 Nov 2014 10-Q 08 Jan 2015 2015 Q1
Q3 2014 10,102,555 +2,164,683 +27% 31 Aug 2014 10-K 25 Nov 2015 2015 FY
Q2 2014 9,955,991 +2,729,568 +38% 31 May 2014 10-Q 14 Jul 2014 2014 Q3
Q1 2014 9,776,167 +2,553,531 +35% 28 Feb 2014 10-Q 10 Apr 2014 2014 Q2
Q4 2013 7,947,872 +747,872 +10% 30 Nov 2013 10-Q 14 Jan 2014 2014 Q1
Q3 2013 7,937,872 +1,263,804 +19% 31 Aug 2013 10-K 14 Nov 2014 2014 FY
Q2 2013 7,226,423 -63,177,160 -90% 31 May 2013 10-Q 17 Jul 2013 2013 Q3
Q1 2013 7,222,636 -62,964,947 -90% 28 Feb 2013 10-Q 11 Apr 2013 2013 Q2
Q4 2012 7,200,000 -62,904,583 -90% 10 Jan 2013 10-Q 10 Apr 2014 2014 Q2
Q3 2012 6,674,068 -63,430,515 -90% 31 Aug 2012 10-K 27 Nov 2013 2013 FY
Q2 2012 70,403,583 31 May 2012 10-Q 12 Jul 2012 2012 Q3
Q1 2012 70,187,583 29 Feb 2012 10-Q 04 Apr 2012 2012 Q2
Q4 2011 70,104,583 30 Nov 2011 10-Q 12 Jan 2012 2012 Q1
Q3 2011 70,104,583 31 Aug 2011 10-K 12 Dec 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.